3: Anti-viral Agents Flashcards
HIV Life cycle
- gp120 receptor on HIV binds to CD4, then co-receptor CCR5 or CXCR4
- entry by fusion
- capsid falls away, exposing genome
- reverse transcription; RNA–> dsDNA; integrase to enter host DNA
- host makes viral proteins
- budding to release virion
Viral life cycle
Attachment (specific proteins or glycoproteins = virus receptors) and entry
capsid falls away, exposing genome
make early (regulatory) and late (structural) proteins, making virion
budding or cytolysis
Influenza Life cycle
- attachment (haemagglutinin - spike protein, binds to virus receptors on cells), entry by endocytosis
- capsid falls away, exposing 8 segments of -ve sense RNA genome
- mRNA made using RNA-dependent RNA polymerase
- Viral proteins made using host ribosomes
- Cytolytic release of virion using neuraminidase
What methods are used for viral diagnostics
PCR
ELISA
Serology
Things to consider when developing anti-viral drugs
Cost
Administration- easy to administer?
Safety - even more than efficacy
Strains - does it deal with all strains?
3 main targets for anti-viral drugs
Viral enzymes
Nucleosides
Specific viral factors
Acyclovir - antiviral drug
Nucleoside analogue
lacks 3’OH group –> chain termination
specific to HSV (herpes simplex virus) :
only HSV has herpes viral thymidine kinase
phosphorylates ACV -> AVMP
ACVMP->ACVTP by cellular enzymes
Remdesevir
Adenosine analogue
chain termination 3 nucleotides downstream of incorporation by twisting shape of DNA/RNA
Developed for Hep C and Ebola
Ideal features of antivirals against influenza
Target unique gene/function
Effective against multiple strains
Easy to administer
Few side effects
Admantanes
Cyclic amines
only active against Influenza A
e.g Admantadine, Rimantadine
Admantadine
resistant to H3N2
targets M2 ion channel
no protons removed from acidic endosome to core of virus particle
M1 matrix protein and nuclear protein interaction remain intact
virus unable to uncut
no viral genome released into host cell
Neuraminidase Inhibitors
Prevent cleavage of sialic acid from host cell membrane
so virus remains attached to host cell
cannot infect other cells
3 Neuraminidase Inhibitors
Tamiflu (oseltamivir) - H1N1 resistant, halved risk of death from swine flu if taken within 48h
Zanamivir (Relenza)
Baloxivir - for influenza A&B - inhibits PA subunit of viral polymerase so prevents viral transcription
What drugs work against Hepatitis C
Protease inhibitors
Polymerase inhibitors
Sustained virological response (SVR)
positive effect of an antiviral drug on reducing the amount of a virus in a patient